Abstract:
A balloon (3) includes: an inflation part (33); a base end-side cone part (32) and a distal end-side cone part in which the diameter of one end that is connected to the inflation part (33) is larger than the diameter of the other end; and a base end-side leg part (31) and a distal end-side leg part. The base end-side cone part (32) has a first connecting part (321), a second connecting part (322), and a third connecting part (323). A first angle (θ21) between a first line segment (L21) connecting a first point (P21) and a third point (P23) and the extension direction, and a second angle (θ22) between a second line segment (L22) connecting a second point (P22) and a fourth point (P24) and the extension direction, are both larger than a third angle (θ23) between a third line segment (L23) connecting the third point (P23) and the fourth point (P24) and the extension direction.
Abstract:
A balloon for medical treatments such as percutaneous transluminal coronary angioplasty (PTCA), delivery of a vascular stents or stent grafts, employs reinforcement materials that are patterned so as to promote consistent folding of the balloon. Also disclosed are methods and apparatus for biocidal treatment using a balloon, including balloons with fiber fabric reinforcements.
Abstract:
A balloon catheter for use in connection with a guidewire comprises an elongated, tubular shaft extending in a longitudinal direction, said shaft having a proximal end and a distal end, an inflatable balloon supported, along the distal end of the shaft, the balloon when inflated including first and second spaced ends and a working surface between the ends, and at least one wire including at least a radiopaque portion for identifying the location of working surface of the balloon.
Abstract:
In embodiments, medical devices, such balloon catheters or stents, can deliver a therapeutic agent to body tissue of a patient. The medical device a therapeutic coating comprising a polydopamine coated therapeutic agent disposed on a surface of the expandable medical device. In some instances, the therapeutic agent may comprise everolimus.
Abstract:
This disclosure relates generally to systems and methods for occluding vessels of the heart and inducing cardioplegic arrest to facilitate the performance of cardiac procedures. An aortic occlusion and perfusion device includes an expandable member configured to expand within the aorta to secure the device within the aorta, and a catheter extending proximally from the expandable member and in fluid communication with the expandable member. The catheter can define a plurality of openings along its length through which blood can pass with one or more of the openings located proximal to the expandable member and one or more of the openings located within the expandable member. The device can also include a flow control sheath disposed around the catheter member such that axial movement of the flow control sheath relative to the catheter selectively occludes or uncovers one or more of the openings located proximal to the expandable member.
Abstract:
Inflatable medical devices and methods for making and using the same are disclosed. The devices can be medical invasive balloons, such as those used for transcutaneous heart valve implantation, such as balloons used for transcatheter aortic-valve implantation. The balloons can have high strength, fiber-reinforced walls.
Abstract:
A balloon catheter in which its distal tip is precisely positionable in order to control movement of the catheter through tortuous vasculature and especially through the lumen of a deployed stent is disclosed. The distal tip of the catheter is rendered radiopaque, at least at its distal-most end, to enable visualization of the position of the catheter and to facilitate placing the catheter in the desired position.
Abstract:
A catheter structure, such as a balloon catheter (30), guidewire, or the like, with markings (32) perceptible outside of the vasculature is for use in determining at a location external to the body the position of the catheter structure relative to a treatment area. Related kits are also disclosed.
Abstract:
The present invention relates to a method of making a balloon catheter comprising providing a hypotube and a guidewire tube, cutting the hypotube to form one or more cuts in a proximal portion of the hypotube and one or more cuts in a distal portion of the hypotube, forming an opening through the wall of the hypotube, passing the guidewire tube through the opening and distally through a lumen defined by the hypotube, forming an inner catheter assembly.